About Doctor:

Dr. Ravindra Nandhana is a Consultant Medical Oncologist & Hemato-Oncologist at Medicover Hospitals, Visakhapatnam. He is one of the best Medical Oncologists with extensive knowledge and experience in treating all types of cancers.

Languages:

Hindi, English, Telugu

Expertise in:

• Chemotherapy for Solid tumors
• Breast cancer, lung cancer, CNS tumors
• Head and neck cancers
• Gastrointestinal cancers
• Genito-urinary cancers
• Gynecologic cancers
• Bone cancer and Soft tissue sarcoma
• Paediatric tumors
• Hemato-lymphoid malignancies
• Acute and chronic Leukemias
• Lymphomas
• Multiple Myeloma
• Bone marrow transplantation
• Immunotherapy
• Targeted therapy (Precision Oncology)
• Hormonal therapy for Breast and prostate cancer
• Procedures
• PICC line insertion
• Bone marrow aspiration and biopsy
• Lumbar puncture and intrathecal therapy
• Preventive oncology and hereditary cancers
• Cancer screening
• Genetic counselling
• Familial cancer treatment
• Palliative and supportive care for advanced cancer

Past Experience:

• February 2021 to July 2021 – Worked as Assistant professor (adhoc), Dept of Medical Oncology, MPMMCC & HBCH, Varanasi.
• August 2020 to January 2021 – Worked as Assistant professor (adhoc), Dept of Medical Oncology, HBCHRC, Visakhapatnam.
• August 2017 to July 2020 – Senior Residency in Medical Oncology at Tata Memorial Hospital, Mumbai.
• March 2017 to July 2017 – Consultant Radiation Oncologist at Surya Global Hospital, Kakinada.
• May 2015 to January 2017 – Senior Resident in Dept of Radiation Oncology at KGH, Visakhapatnam.
• 2012 to 2015 – Resident in Dept of Radiation Oncology, GSL Medical College, Rajahmundry.

Awards & Recognitions:

• Cleared European Society of Medical Oncology (ESMO) examination in 2016, Chennai, India.
• 2nd prize in Hematology quiz organized by Mumbai Hematology group, 2020.
• Completed Professional Diploma in Clinical Research (PDCR) examination in January 2021.
• All India9th rank in DM entrance exam (Medical Oncology), NEET (2017).
• Secured 99th rank in Engineering and Medical Common Entrance Test (EAMCET) in Andhra Pradesh (2005).

Publications:

• Daratumumab and its efficacy in refractory myeloma with anemia.Cancer Res Stat Treat 2020; 3:832-5. DOI: 10.4103/crst.crst_283_20.
• Pulmonary sarcomatoid carcinoma: Retrospective analysis from a single center. e21188 poster in JCO; https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.e21188.
• Resistance mechanisms to epidermal growth factor receptor inhibitors in non-small cell lung cancer.Year: 2020, Volume: 3, Issue: 4, Page: 801-807.DOI: 10.4103/crst.crst_357_20.
• Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice. Published: July 22, 2021. https://doi.org/10.1371/journal.pone.0253722
• Real world data of treatment free remission in patients with chronic myeloid leukemia (CML) treated at tertiary care oncology Centre from India. 06/12/20; 297883; PB1967

Memberships:

• European Society of Clinical Oncology (ESMO)
• American Society of Clinical Oncology (ASCO)
• Indian Cooperative Oncology Network (ICON)
• Association of Radiation Oncologists of India (AROI)
• AP State Medical Council